May 29, 2014
Clinical Trial Results Signal an Advance for Idiopathic Pulmonary Fibrosis
 After a string of failed clinical trials in idiopathic pulmonary fibrosis, the results from studies of two experimental medications signal progress in the treatment of this deadly disease, according to researchers at National Jewish Health and around the nation. The trial results were presented May 18 at the 2014 American Thoracic Society annual conference and simultaneously published online in the New England Journal of Medicine. Read more.
April 30, 2014
National Jewish Health Named Lung Cancer Screening Center of Excellence
 National Jewish Health has been selected as a Lung Cancer Screening Center of Excellence by the Lung Cancer Alliance. The designation signifies that the National Jewish Health program implements screening in a safe, responsible, effective and equitable manner. Read more.
April 24, 2014
National Jewish Health Welcomes First Steps at Regulation of E-Cigarettes
 National Jewish Health welcomes the U.S. Food and Drug Administration’s (FDA) initial efforts to protect the health of Americans, especially young people, by regulating e-cigarettes as well as other tobacco products. Read more
April 1, 2014
FDA Approves Nation's First Prescription-Strength Tablet To Treat Hay Fever Allergies
 For the first time in the U.S., the Food and Drug Administration (FDA) has approved the use of daily tablets to treat hay fever, particularly allergies to grass and ragweed pollen. Read more.
View all 2014 releases.
|
Search for News
|